Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities


Sousa-Pinto B., Anto A., Berger M., Dramburg S., Pfaar O., Klimek L., ...More

Clinical and Translational Allergy, vol.12, no.11, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 11
  • Publication Date: 2022
  • Doi Number: 10.1002/clt2.12208
  • Journal Name: Clinical and Translational Allergy
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, Food Science & Technology Abstracts, Directory of Open Access Journals
  • Keywords: allergic rhinitis, app, chronic rhinosinusitis, mHealth, ALLERGIC RHINITIS, MOBILE TECHNOLOGY, MASK, DISEASES, ASTHMA, PRODUCTIVITY, VALIDATION, MANAGEMENT, INNOVATION, CHILDREN
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

© 2022 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.Digital health is an umbrella term which encompasses eHealth and benefits from areas such as advanced computer sciences. eHealth includes mHealth apps, which offer the potential to redesign aspects of healthcare delivery. The capacity of apps to collect large amounts of longitudinal, real-time, real-world data enables the progression of biomedical knowledge. Apps for rhinitis and rhinosinusitis were searched for in the Google Play and Apple App stores, via an automatic market research tool recently developed using JavaScript. Over 1500 apps for allergic rhinitis and rhinosinusitis were identified, some dealing with multimorbidity. However, only six apps for rhinitis (AirRater, AllergyMonitor, AllerSearch, Husteblume, MASK-air and Pollen App) and one for rhinosinusitis (Galenus Health) have so far published results in the scientific literature. These apps were reviewed for their validation, discovery of novel allergy phenotypes, optimisation of identifying the pollen season, novel approaches in diagnosis and management (pharmacotherapy and allergen immunotherapy) as well as adherence to treatment. Published evidence demonstrates the potential of mobile health apps to advance in the characterisation, diagnosis and management of rhinitis and rhinosinusitis patients.